• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALEC

ALEC

Alector, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.77

-0.17 (-8.97%)

Rating:D+

Company Profile

CEO

Arnon Rosenthal

IPO Date

2019-02-07

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.89

Prev. Close

$1.95

Day Low

$1.71

Day High

$1.94

52W Low

$1.09

52W High

$3.40

Market Cap

$0.20B

Volume

1.69M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.3%

Avg Negative

11.6%

Avg Neutral

43.0%

News Feed

Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients

Benzinga·7/29/2021·↓ negative

Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation

GlobeNewsWire·7/29/2021·↑ positive

Alector to Present New Data from Frontotemporal Dementia and Alzheimer's Disease Programs at the 2021 Alzheimer's Association International Conference

GlobeNewsWire·7/21/2021·↑ positive

Alector's (ALEC) Shares March Higher, Can It Continue?

Zacks Investment Research·7/12/2021·↑ positive

Why Alector Zoomed 12% Higher Today

The Motley Fool·7/6/2021·↑ positive

Glaxo (GSK)/Alector Ink Deal for Neurodegenerative Indications

Zacks Investment Research·7/5/2021·↓ negative

Alector (ALEC) Up on Tie-Up With Glaxo for Neurological Diseases

Zacks Investment Research·7/5/2021·↑ positive

Alector (ALEC) Stock Jumps 57.1%: Will It Continue to Soar?

Zacks Investment Research·7/5/2021·↑ positive

Why Alector Blasted Higher Today

The Motley Fool·7/2/2021·↑ positive

Don't Miss What Sent These 2 Little-Known Nasdaq Newsmakers Soaring

The Motley Fool·7/2/2021·↑ positive